Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

In principle, proton therapy offers a substantial clinical advantage over conventional photon
therapy. This is because of the unique depth-dose characteristics of protons, which can be …

Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Objective To present a summary of the 2016 version of the European Association of Urology
(EAU)-European Society for Radiotherapy & Oncology (ESTRO)-International Society of …

Purpose Men with localized prostate cancer often are treated with external radiotherapy (RT)
over 8 to 9 weeks. Hypofractionated RT is given over a shorter time with larger doses per …

Background & Aims Proton beam radiotherapy (PBT) has recently been applied to treat
hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based …

The physics of proton therapy has advanced considerably since it was proposed in 1946.
Today analytical equations and numerical simulation methods are available to predict and …

Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease.
However, the current definitions of high-risk prostate cancer include a heterogeneous group …

Purpose To report the genitourinary (GU) and gastrointestinal (GI) morbidity and erectile
dysfunction in a randomized trial comparing 2 methods of dose escalation for high-and …

Background It is not known whether short-term androgen-deprivation therapy (ADT) before
and during radiotherapy improves cancer control and overall survival among patients with …